Workflow
TMMT(300334)
icon
Search documents
津膜科技中标滨州第二再生水项目
Mei Ri Jing Ji Xin Wen· 2025-09-30 05:07
Core Insights - The company, Jintai Technology, has successfully won the bid for the EPC engineering equipment procurement and installation debugging project for the Binzhou Second Reclaimed Water Plant (Phase I), marking a new breakthrough in the reclaimed water recycling field in the East China region [1] Company Summary - Jintai Technology has achieved a significant milestone by securing a project that enhances its presence in the reclaimed water recycling sector [1]
津膜科技中标延长石油海测滩矿井水处理站膜系统采购项目
Xin Lang Cai Jing· 2025-09-29 06:35
据津膜科技消息,近日,津膜科技中标陕西延长石油物资集团上海有限公司海测滩矿井及选煤厂矿井水 处理站超滤膜系统采购项目。 ...
天津国企改革板块9月25日跌0.72%,津投城开领跌,主力资金净流出3827.19万元
Sou Hu Cai Jing· 2025-09-25 08:52
Market Overview - On September 25, the Tianjin state-owned enterprise reform sector fell by 0.72% compared to the previous trading day, with Jintou Chengkai leading the decline [1] - The Shanghai Composite Index closed at 3853.3, down 0.01%, while the Shenzhen Component Index closed at 13445.9, up 0.67% [1] Stock Performance - The following stocks in the Tianjin state-owned enterprise reform sector showed notable performance: - Baili Electric (600468) closed at 6.73, up 4.02% with a trading volume of 1.021 million shares and a turnover of 693 million yuan [1] - Jintou Chengkai (600322) closed at 2.35, down 6.37% with a trading volume of 868,900 shares and a turnover of 210 million yuan [2] - Other stocks such as Tianjin Port (600717) and Taida Co. (000652) also experienced declines of 1.28% and 1.45% respectively [1][2] Capital Flow Analysis - The Tianjin state-owned enterprise reform sector saw a net outflow of 38.27 million yuan from main funds, while speculative funds had a net inflow of 53.41 million yuan, and retail investors experienced a net outflow of 15.13 million yuan [2] - Specific stock capital flows included: - Baili Electric had a net inflow of 20.84 million yuan from main funds, while retail investors saw a net outflow of 4.25 million yuan [3] - Tianjin Port had a net inflow of 9.34 million yuan from speculative funds, but a net outflow of 9.81 million yuan from retail investors [3]
津膜科技(300334) - 关于间接控股股东合伙人之间转让份额及新合伙人入伙的进展公告
2025-09-17 12:13
证券代码:300334 证券简称:津膜科技 公告编码:2025-075 天津膜天膜科技集团股份有限公司 三、备查文件 1、共青城航科国惠环保产业投资中心(有限合伙)《告知函》 特此公告。 关于间接控股股东合伙人之间转让份额及新合伙人入伙的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 一、前期披露情况 天津膜天膜科技集团股份有限公司(以下简称"公司")间接控股股东共青城航科国 惠环保产业投资中心(有限合伙)(简称"共青城航科")近期发生有限合伙人之间转让 合伙份额、新合伙人入伙并认购新增合伙份额事项。具体内容详见公司于 2025 年 9 月 1 日、 2025 年 9 月 8 日在巨潮资讯网 (http://www.cninfo.com.cn)披露的《关于间接控股股东合 伙人之间转让份额及新合伙人入伙的公告》(公告编号:2025-069)、《关于间接控股股 东合伙人之间转让份额及新合伙人入伙的进展公告》(公告编号:2025-071)。 二、进展情况 公司于近日收到共青城航科的告知函,共青城航科各合伙人就合伙人变更、合伙份额 转让及新增合伙份额等相关事 ...
津膜科技(300334) - 关于公司诉讼案件的进展公告
2025-09-16 12:10
证券代码:300334 证券简称:津膜科技 公告编码:2025-074 天津膜天膜科技集团股份有限公司 关于公司诉讼案件的进展公告 提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 3、涉案金额:不涉及具体金额 4、对公司损益产生的影响:本案件尚处于再审审查阶段,公司已对本诉讼案件 所涉及的应收账款进行单独测试并计提坏账准备。由于再审审查的最终判决结果存在 不确定性,敬请广大投资者谨慎决策,注意投资风险。 天津膜天膜科技集团股份有限公司(以下简称"公司"或"被申请人")于近日 收到应诉通知书((2025)最高法民申 3301 号),现就有关情况公告如下: 一、本次诉讼的基本情况及前期信息披露情况 公司与被告西安市临潼区城市投资集团有限公司(以下简称 "临潼城投公司")、 西安临潼旅游商贸开发区管理委员会(以下简称 "管委会"或"申请人")及第三人 西安市临潼区绿源市政工程有限公司(以下简称 "西安绿源公司")因股东损害公司 债权人利益责任纠纷,为维护公司合法权益,根据相关法律规定,公司向天津市第三 中级人民法院提起诉讼。 2024 年 ...
调研速递|津膜科技接受多家投资者调研,下半年业绩及业务布局引关注
Xin Lang Cai Jing· 2025-09-12 09:03
Core Viewpoint - Tianjin Membrane Technology Group Co., Ltd. (referred to as "Tianjin Membrane Technology") held an investor meeting on September 11, 2025, to discuss its performance, business development, and market expansion, emphasizing its goal to enhance performance in the second half of the year [1]. Summary by Relevant Categories Performance and Business Development - The company aims to improve its performance in the second half of 2025, with specific details to be disclosed in future reports [1]. - Tianjin Membrane Technology has optimized its asset quality and business structure since its listing, planning to increase R&D for differentiated products and strengthen marketing efforts [1]. Business Segments and Market Opportunities - The core business focuses on separation membrane products and membrane application system integration, with a significant increase in new orders in the first half of 2025 [1]. - The company plans to enhance its membrane technology, including improving hollow fiber membrane performance and expanding into seawater desalination and overseas markets [1]. Innovation and Technology - The company has established an innovative culture internally, encouraging innovation through the formation of task forces and market-based incentives [1]. - In 2025, the company will undergo digital transformation, improving management and production systems to reduce costs [1]. Market Expansion and Strategy - The company has implemented effective measures for market expansion, resulting in a significant year-on-year increase in new contract amounts and the addition of industrial and overseas clients [1]. - The membrane industry is rapidly developing as a national strategic emerging industry, with strong demand in water treatment and environmental sectors [1]. Research and Development - R&D investments focus on improving existing materials and products, as well as developing cutting-edge technologies, including modified membrane materials [1]. - The company is actively applying for patents to protect its core competitiveness in line with its R&D progress [1]. Financial Outlook - The company anticipates a slowdown in converting new orders into performance, with specific details to be monitored in the upcoming semi-annual report [1]. - The company aims to enhance new product promotion and marketing in the second half of the year, stabilize project operations, and improve overall performance [1]. Competitive Advantages - The core competitiveness includes a strong technical foundation in separation membrane materials, a leading research platform, and performance across multiple application fields [1]. - The company has seen growth in overseas orders, particularly in Southeast Asia, and plans to continue focusing on international markets as a key growth area [1].
津膜科技(300334) - 300334津膜科技投资者关系管理信息20250912
2025-09-12 07:59
Group 1: Financial Performance and Growth - The company aims to enhance profits in the second half of 2025, focusing on operational improvements and market strategies [2] - In the first half of 2025, the company achieved significant growth in new orders, particularly in core business segments [3][5] - The company reported a slowdown in revenue growth due to challenges in converting new orders into actual performance [10] Group 2: Market Strategy and Development - The company plans to strengthen its market position by focusing on differentiated products and technology development [3] - Key business areas include seawater desalination, industrial water resource management, and new industrial separation technologies [3][5] - The company has seen a notable increase in overseas orders, particularly in Southeast Asia, Russia, and Central Asia, despite facing international competition [13] Group 3: Innovation and Technology - The company has increased R&D investments in advanced membrane materials and technologies, aiming to enhance product performance and reduce costs [8][12] - New technologies introduced include the "Pulse Aeration MBR Membrane Equipment" and "Pressure-type Hollow Fiber Membrane Filtration Equipment," recognized as internationally advanced [21] - The company has implemented digital transformation initiatives, including ERP upgrades and AI applications, to improve operational efficiency [6][8] Group 4: Competitive Advantage and Industry Position - The company's core competitive advantage lies in its deep technical expertise in separation membrane materials and products, supported by a strong R&D platform [22] - The company has established a comprehensive patent system to protect its innovations and maintain a competitive edge in the market [19] - The company emphasizes quality improvement and customer feedback, leading to increased order growth in core products [10][12]
津膜科技:关于持股5%以上股东减持计划届满实施完成的公告
Zheng Quan Ri Bao· 2025-09-10 12:42
(文章来源:证券日报) 证券日报网讯 9月10日晚间,津膜科技发布公告称,公司近日收到公司股东高新投资发展有限公司(简 称"高新公司")《关于股份减持计划进展情况的告知函》,高新公司减持计划已实施完成,2025年6月 11日至2025年9月10日减持计划期间内,通过集中竞价方式减持公司股份299.8万股,占公司总股本 0.9925%。 ...
津膜科技(300334.SZ):高新公司累计减持0.9925%股份
Ge Long Hui A P P· 2025-09-10 09:24
Group 1 - The core point of the article is that Tianmo Technology (300334.SZ) has completed a share reduction plan initiated by Gaoxin Company, which involved selling 2.998 million shares, accounting for 0.9925% of the company's total share capital [1] Group 2 - The share reduction took place between June 11, 2025, and September 10, 2025, through centralized bidding [1] - The completion of the share reduction plan indicates a strategic move by Gaoxin Company regarding its stake in Tianmo Technology [1]
津膜科技(300334) - 关于持股5%以上股东减持计划期满实施完成的公告
2025-09-10 09:02
证券代码:300334 证券简称:津膜科技 公告编码:2025-073 天津膜天膜科技集团股份有限公司 关于持股5%以上股东减持计划届满实施完成的公告 持股 5%以上股东高新投资发展有限公司保证向本公司提供的信 息内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的 信息一致。 一、股东股份减持计划届满实施完成及实施情况 2025年5月19日,天津膜天膜科技集团股份有限公司(以下简称"公司"或"津 膜科技")披露了《关于持股5%以上股东减持计划预披露的公告》(公告编号: 2025-041)。根据公告,公司股东高新投资发展有限公司(以下简称"高新公司") 计划在公告之日起十五个交易日后的三个月内以集中竞价方式减持本公司股份不 超过3,020,653股(即不超过本公司总股本比例1%)。2025年7月11日,公司披露了 《关于持股5%以上股东减持公司股份触及1%整数倍的公告》(公告编号: 2025-057)。 公司近日收到高新公司《关于股份减持计划进展情况的告知函》,高新公司 减持计划已实施完成,2025年6月11日至2025年9月10日减持计划期间内 ...